DD294260A5 - Verfahren zur herstellung von substituierten pyrrolverbindungen - Google Patents

Verfahren zur herstellung von substituierten pyrrolverbindungen Download PDF

Info

Publication number
DD294260A5
DD294260A5 DD90340498A DD34049890A DD294260A5 DD 294260 A5 DD294260 A5 DD 294260A5 DD 90340498 A DD90340498 A DD 90340498A DD 34049890 A DD34049890 A DD 34049890A DD 294260 A5 DD294260 A5 DD 294260A5
Authority
DD
German Democratic Republic
Prior art keywords
group
alkyl
radicals
general formula
compound
Prior art date
Application number
DD90340498A
Other languages
German (de)
English (en)
Inventor
G Dannhardt
Ludwig Steindl
Matthias Lehr
Original Assignee
Kkk
������@������������k��
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kkk, ������@������������k�� filed Critical Kkk
Publication of DD294260A5 publication Critical patent/DD294260A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/323—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to the ring nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/33—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/337—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Diabetes (AREA)
  • Rheumatology (AREA)
  • Hematology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyrrole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DD90340498A 1989-05-11 1990-05-09 Verfahren zur herstellung von substituierten pyrrolverbindungen DD294260A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3915450A DE3915450A1 (de) 1989-05-11 1989-05-11 Substituierte pyrrolverbindungen und deren anwendung in der pharmazie

Publications (1)

Publication Number Publication Date
DD294260A5 true DD294260A5 (de) 1991-09-26

Family

ID=6380477

Family Applications (1)

Application Number Title Priority Date Filing Date
DD90340498A DD294260A5 (de) 1989-05-11 1990-05-09 Verfahren zur herstellung von substituierten pyrrolverbindungen

Country Status (13)

Country Link
EP (1) EP0397175B1 (ja)
JP (1) JP2796876B2 (ja)
KR (1) KR0173455B1 (ja)
AR (1) AR246256A1 (ja)
AT (1) ATE98246T1 (ja)
AU (1) AU637098B2 (ja)
CA (1) CA2016501C (ja)
DD (1) DD294260A5 (ja)
DE (2) DE3915450A1 (ja)
DK (1) DK0397175T3 (ja)
ES (1) ES2062160T3 (ja)
FI (1) FI95258C (ja)
NO (1) NO174892C (ja)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6492413B2 (en) 1993-01-15 2002-12-10 G.D. Searle & Co. 3.4-diaryl thiophenes and analogs thereof having use as antiinflammatory agents
CA2297592A1 (en) * 1993-01-15 1994-07-21 G.D. Searle & Co. Novel 3,4-diaryl thiophenes and analogs thereof having use as antiinflammatory agents
US5474995A (en) * 1993-06-24 1995-12-12 Merck Frosst Canada, Inc. Phenyl heterocycles as cox-2 inhibitors
DE4338770A1 (de) * 1993-11-12 1995-05-18 Matthias Dr Lehr Indol-2-alkansäuren und ihre Derivate als Hemmstoffe der Phospholipase A¶2¶
DE4419315A1 (de) * 1994-06-01 1995-12-07 Merckle Gmbh Heteropyrrolizinverbindungen und deren Anwendung in der Pharmazie
DE4419246A1 (de) * 1994-06-01 1995-12-07 Merckle Gmbh Heteroarylsubstituierte Pyrrolizinverbindungen und deren Anwendung in der Pharmazie
DE4419247A1 (de) * 1994-06-01 1995-12-07 Merckle Gmbh Sulfonylierte Pyrrolizincarbonsäureamide und deren Anwendung in der Pharmazie
ATE255090T1 (de) * 1996-08-01 2003-12-15 Merckle Gmbh Acylpyrroldicarbonsäuren und acylindoldicarbonsäuren sowie ihre derivate als hemmstoffe der cytosolischen phospholipase a2
TR200400691T4 (tr) * 2000-01-28 2004-11-22 Merckle Gmbh 6(-4-Klorfenil)-2,-2-Dimetil-7-Fenil-2, 3-Dihidro-1H-Pirrolizin-5-İl- Asetik asit üretim yöntemi
DE10004157A1 (de) * 2000-02-01 2001-08-02 Merckle Gmbh Chem Pharm Fabrik 4-Pyridyl-und 2,4-Pyrimidinyl-substituierte Pyrrolderivate und ihre Anwendung in der Pharmazie
KR20020007836A (ko) * 2000-07-19 2002-01-29 신덕호 골프공
DE10141285A1 (de) 2001-08-23 2003-03-27 Merckle Gmbh Verfahren zur Herstellung von 6-(4-Chlorphenyl)-2,2-dimethyl-7-phnyl-2,3-dihydro-1H-pyrrolizin-5-yl-essigsäure
DE102005012971A1 (de) * 2005-03-21 2006-09-28 Merckle Gmbh Polymorphe Form von 6-(4-Chlorphenyl)-2,2-dimethyl-7-phenyl-2,3-dihydro-1H-pyrrolizin-5-yl-essigsäure

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1156489A (en) * 1965-04-30 1969-06-25 Firmenich & Cie Alcoholic Flavouring Agents
AU429651B2 (en) * 1968-08-08 1972-11-01 Commonwealth Scientific And Industrial Research Organization Antiviral 6, 7 dihydro 5h pyrrolizines and related compounds
DE2062984A1 (en) * 1970-12-21 1972-06-22 Messerschmitt, Thilo, 8094 Reitmehring; Dobeneck, Henning von, 8021 Icking 2-unsubstd-5-formyl-pyrrole prepn - by catalytic hydrogenation of 2-halo-5-formyl-pyrroles
DE2261965A1 (de) * 1971-12-23 1973-06-28 Continental Pharma Derivate der pyrrolessigsaeure und deren salze sowie von pyrrolacetonitril, verfahren zur herstellung dieser verbindungen, diese verbindungen enthaltende pharmazeutische produkte und verwendung dieser verbindungen und produkte
JPS5217074B2 (ja) * 1972-04-25 1977-05-13
JPS6011899B2 (ja) * 1978-12-27 1985-03-28 財団法人相模中央化学研究所 ピロ−ル酢酸誘導体の製造方法
JPS5687558A (en) * 1979-11-27 1981-07-16 Mcneilab Inc Manufacture of pyrrolee22acetic acids
US4284562A (en) * 1979-11-27 1981-08-18 Mcneilab, Inc. Process for preparing pyrrole-2-acetic acids
JPS56100784A (en) * 1980-01-16 1981-08-12 Yoshitomi Pharmaceut Ind Ltd Indolizine derivative
US4327221A (en) * 1980-10-15 1982-04-27 American Home Products Corporation 2-Substituted-3-hydroxythiazolo(2,3-8)-thiazolium salts and mesoionic didehydro derivatives thereof
WO1982002044A1 (en) * 1980-12-15 1982-06-24 Corp Ethyl Preparation of pyrrole esters
DE3368416D1 (en) * 1982-02-25 1987-01-29 Beecham Group Plc Aroyl pyrrolizine compounds, process for their preparation and pharmaceutical compositions containing them
FR2539417A1 (fr) * 1983-01-13 1984-07-20 Rhone Poulenc Sante Nouveaux pyrrolo-1, 2 heterocycles, leur preparation et les medicaments qui les contiennent
FR2557111B1 (fr) * 1983-12-21 1986-04-11 Rhone Poulenc Sante Nouveaux derives ortho-condenses du pyrrole, leur preparation et les medicaments qui les contiennent
IL78834A (en) * 1985-05-23 1992-07-15 Smithkline Beckman Corp 2,3-dihydro-5-(1,4-dihydropyridin-4-yl)-6-phenylimidazo(2,1-b)thiazoles and 6,7-dihydro-3-(1,4-dihydropyridin-4-yl)-2-phenyl-5h-imidazo(2,1-b)(1,3)thiazines and their use as intermediates in a process for preparing the corresponding pyridyl-substituted imidazo(2,1-b)thiazoles and 5h-imidazo(2,1-b)(1,3)thiazines
FR2601016B1 (fr) * 1986-07-04 1988-10-07 Rhone Poulenc Sante Nouveaux derives du 1h,3h-pyrrolo (1,2-c) thiazole, leur preparation et les compositions pharmaceutiques qui les contiennent
FR2617484B1 (fr) * 1987-07-02 1989-10-20 Rhone Poulenc Sante Procede de preparation de l'acide (pyridyl-3)-3 1h-3h-pyrrolo (1,2-c) thiazolecarboxylique-7 dextrogyre

Also Published As

Publication number Publication date
DE3915450A1 (de) 1990-11-15
CA2016501C (en) 2001-10-09
NO902084D0 (no) 1990-05-10
FI902316A0 (fi) 1990-05-09
NO902084L (no) 1990-11-12
DK0397175T3 (da) 1994-02-14
NO174892C (no) 1994-07-27
FI95258C (fi) 1996-01-10
CA2016501A1 (en) 1990-11-11
ATE98246T1 (de) 1993-12-15
AU5480090A (en) 1990-11-15
FI95258B (fi) 1995-09-29
AR246256A1 (es) 1994-07-29
KR0173455B1 (ko) 1999-02-01
AU637098B2 (en) 1993-05-20
DE59003753D1 (de) 1994-01-20
ES2062160T3 (es) 1994-12-16
JP2796876B2 (ja) 1998-09-10
EP0397175A1 (de) 1990-11-14
NO174892B (no) 1994-04-18
JPH035455A (ja) 1991-01-11
EP0397175B1 (de) 1993-12-08
KR900018103A (ko) 1990-12-20

Similar Documents

Publication Publication Date Title
DE69826127T2 (de) 2-substituierte 4,5-diarylimidazole
DE60030574T2 (de) Fünfgliedrige derivate von heterozyklen und ihre verwendung als monoaminoxidase-inhibitoren
EP0763037B1 (de) [a]-ANNELIERTE PYRROLDERIVATE UND DEREN ANWENDUNG IN DER PHARMAZIE
EP0763036B1 (de) [a]-ANNELIERTE PYRROLDERIVATE UND DEREN ANWENDUNG IN DER PHARMAZIE
EP0804437B1 (de) [a]-ANNELIERTE PYRROLDERIVATE UND DEREN ANWENDUNG IN DER PHARMAZIE
DE2102746A1 (de) 5 Aroylpyrrole
DD294260A5 (de) Verfahren zur herstellung von substituierten pyrrolverbindungen
DE2149249A1 (de) 6-Arylpyrimidine
DE3315902A1 (de) 7-oxabicycloheptanhydra zonprostaglandin-analoge und arzneimittel
EP0496238A1 (de) Substituierte Benzoxazepine und Benzthiazepine, Verfahren zu ihrer Herstellung und ihre Verwendung in Arzneimitteln
DE2705582A1 (de) Neue derivate des 1,2-dithiols, ihre herstellung und die sie enthaltenden zusammensetzungen
DE3035086A1 (de) Cyclohexancarbonsaeurederivate, verfahren zu ihrer herstellung und sie enthaltende mittel
DE1695044A1 (de) Verfahren zur Herstellung von neuen,substituierten Phenylessigsaeuren und deren Estern
DE4325204A1 (de) Acylpyrrolalkansäuren und ihre Derivate als Hemmstoffe der Phospholipase A¶2¶
DE2647041C2 (de) 3-Aminomethylen-6,7-dimethoxy-2- methyl-4-oxo-1,2,3,4-tetrahydro-1-chinolincarbonsäureäthylester
EP0061056A1 (de) 5,6-Dimethyl-pyrrolo(2,3-b)pyridine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
EP0095641B1 (de) Chinazolinonderivate, Verfahren zu ihrer Herstellung und ihre Verwendung in Arzneimitteln
DE3242442A1 (de) Benzylidenderivate, verfahren zu ihrer herstellung und sie enthaltende arzneimittel
DE3888694T2 (de) Isoprenoid-derivate und arzneimittelzubereitung, die diese enthält.
EP0104483A2 (de) Sulfamoylbenzophenon-Derivate, Verfahren zu ihrer Herstellung, ihre Verwendung sowie pharmazeutische Präparate auf Basis dieser Verbindungen
EP0280868B1 (de) Neue Imidazo- und Triazolothiadiazine, Verfahren zu ihrer Herstellung, die sie enthaltenden Arzneimittel und ihre Verwendung, sowie einige bei der Herstellung der genannten Verbindungen gebildete Zwischenprodukte
DE68915750T2 (de) Kathecholverbindungen, verfahren zur herstellung und arzneimittelzubereitung, die diese enthält.
EP0064026B1 (de) Neue dioxaheterocyclische Verbindungen, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Zusammensetzungen
EP1232158A1 (de) Antiinflammatorische oxo- und hydroxyderivate von pyrrolizinen und deren anwendung in der pharmazie
DE2634910A1 (de) Quartaere kondensierte heterocyclische salze sowie antidiabetika

Legal Events

Date Code Title Description
IF04 In force in the year 2004

Expiry date: 20100510